Evidence map›Paper›PMID 34264308›Full record

ArticleBrain : a journal of neurology2022

Balance between competing spectral states in subthalamic nucleus is linked to motor impairment in Parkinson's disease.

Saed Khawaldeh, Gerd Tinkhauser, Flavie Torrecillos, Shenghong He, Thomas Foltynie, Patricia Limousin, Ludvic Zrinzo, Ashwini Oswal, Andrew J Quinn, Diego Vidaurre and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation.Movement disorders : official journal of the Movement Disorder Society · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023
    Article
  17. Article
  18. Article
  19. Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  20. Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease.Neuromodulation : journal of the International Neuromodulation Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Saed KhawaldehMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.
Gerd TinkhauserMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.
Flavie TorrecillosMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.
Shenghong HeMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.
Thomas FoltynieUnit of Functional Neurosurgery, Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London WC1B 5EH, UK.
Patricia LimousinUnit of Functional Neurosurgery, Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London WC1B 5EH, UK.
Ludvic ZrinzoUnit of Functional Neurosurgery, Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London WC1B 5EH, UK.
Ashwini OswalMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.ORCID 0000-0002-0152-9294
Andrew J QuinnOxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford OX3 7JX, UK.
Diego VidaurreOxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford OX3 7JX, UK.ORCID 0000-0002-9650-2229
Huiling TanMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.ORCID 0000-0001-8038-3029
Vladimir LitvakWellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London WC1N 3AR, UK.
Andrea KühnDepartment of Neurology, Charitè-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Mark WoolrichNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Peter BrownMRC Brain Network Dynamics Unit, University of Oxford, Oxford OX1 3TH, UK.
University of Oxford · GBUniversity College London · GBWellcome Centre for Human Neuroimaging · GBAarhus University · DKCharité - Universitätsmedizin Berlin · DEUniversity of Bern · CH

Funding

Medical Research Council G0901503Medical Research Council MC_UU_00003/2Medical Research Council MC_UU_12024/1Medical Research Council MR/L023784/2Medical Research Council MR/V00655X/1Wellcome Trust 098369Wellcome Trust 106183Wellcome Trust 215573
6 · The paper itself

Abstract

Exaggerated local field potential bursts of activity at frequencies in the low beta band are a well-established phenomenon in the subthalamic nucleus of patients with Parkinson's disease. However, such activity is only moderately correlated with motor impairment. Here we test the hypothesis that beta bursts are just one of several dynamic states in the subthalamic nucleus local field potential in Parkinson's disease, and that together these different states predict motor impairment with high fidelity. Local field potentials were recorded in 32 patients (64 hemispheres) undergoing deep brain stimulation surgery targeting the subthalamic nucleus. Recordings were performed following overnight withdrawal of anti-parkinsonian medication, and after administration of levodopa. Local field potentials were analysed using hidden Markov modelling to identify transient spectral states with frequencies under 40 Hz. Findings in the low beta frequency band were similar to those previously reported; levodopa reduced occurrence rate and duration of low beta states, and the greater the reductions, the greater the improvement in motor impairment. However, additional local field potential states were distinguished in the theta, alpha and high beta bands, and these behaved in an opposite manner. They were increased in occurrence rate and duration by levodopa, and the greater the increases, the greater the improvement in motor impairment. In addition, levodopa favoured the transition of low beta states to other spectral states. When all local field potential states and corresponding features were considered in a multivariate model it was possible to predict 50% of the variance in patients' hemibody impairment OFF medication, and in the change in hemibody impairment following levodopa. This only improved slightly if signal amplitude or gamma band features were also included in the multivariate model. In addition, it compares with a prediction of only 16% of the variance when using beta bursts alone. We conclude that multiple spectral states in the subthalamic nucleus local field potential have a bearing on motor impairment, and that levodopa-induced shifts in the balance between these states can predict clinical change with high fidelity. This is important in suggesting that some states might be upregulated to improve parkinsonism and in suggesting how local field potential feedback can be made more informative in closed-loop deep brain stimulation systems.

Indexed as

Deep Brain StimulationMotor DisordersParkinson DiseaseSubthalamic NucleusHumansLevodopaLevodopadeep brain recordinghidden Markov modellingmachine learningParkinson’s diseasetime-series analysis

Identifiers

PMID34264308
PMCPMC8967096
OpenAlexW3180762017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.